South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.
McDonald’s resists giving sales data to Hungry Jack’s board, CEO in row over misleading ads
ANZ, ex-money markets head settle case alleging sacking after complaints
Global Payments’ tie-up with School Bytes faces scrutiny by competition cop
Optus taken to court by ACMA over massive data breach
Mark Latham’s homophobic tweet sparked ‘graphic’ abuse, death threats, Sydney MP says
Equity = equal: Western Power, Ventia must pay same in Parkerville bushfire costs, court says
FWC’s ‘harsh’ comment about Mantle Group gave rise to appearance of bias, High Court told
Judge won’t dock developer’s case against NSW Ports over privatisation deal
A New South Wales developer’s competition case against NSW Ports over a ports privatisation agreement looks bound for the High Court after a judge found a related ACCC proceeding did not bar it from bringing the case, which will challenge a Full Court finding that the ports operator was shielded by derivative Crown immunity.